Scarica l'app Stockscreener
57.31
3.04%
-1.795
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$59.10
Aprire:
$59.11
Volume 24 ore:
2.37M
Relative Volume:
1.13
Capitalizzazione di mercato:
$8.73B
Reddito:
$3.46B
Utile/perdita netta:
$-9.40M
Rapporto P/E:
-238.39
EPS:
-0.2404
Flusso di cassa netto:
$51.30M
1 W Prestazione:
+4.58%
1M Prestazione:
-3.96%
6M Prestazione:
+58.23%
1 anno Prestazione:
+44.32%
Intervallo 1D:
$0.00
$0.00
Intervallo di 1 settimana:
$54.68
$60.66
Portata 52W:
$32.37
$66.98
Bruker Corp Stock (BRKR) Company Profile
Nome
Bruker Corp
Settore
Industria
Telefono
978663-3660
Indirizzo
40 MANNING RD, BILLERICA, MA
Compare BRKR vs ABT, MDT, SYK, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BRKR
Bruker Corp
|
57.31 | 8.73B | 3.46B | -9.40M | 51.30M | -0.2404 |
ABT
Abbott Laboratories
|
102.51 | 177.38B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
96.59 | 123.55B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
307.08 | 117.79B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
46.01 | 66.68B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
90.09 | 51.93B | 6.30B | 1.07B | 1.09B | 1.8406 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-10-14 | Downgrade | JP Morgan | Overweight → Neutral |
| 2026-09-09 | Iniziato | UBS | Neutral |
| 2026-06-02 | Ripresa | Wolfe Research | Peer Perform |
| 2025-12-10 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2025-12-09 | Iniziato | Goldman | Sell |
| 2025-11-20 | Iniziato | Rothschild & Co Redburn | Buy |
| 2025-05-22 | Downgrade | Citigroup | Buy → Neutral |
| 2024-12-19 | Iniziato | Guggenheim | Buy |
| 2024-12-10 | Iniziato | UBS | Neutral |
| 2024-12-05 | Aggiornamento | Goldman | Sell → Neutral |
| 2024-10-15 | Iniziato | Barclays | Overweight |
| 2024-09-30 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-02-14 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2023-12-19 | Iniziato | Wells Fargo | Equal Weight |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2022-10-21 | Iniziato | UBS | Buy |
| 2022-08-22 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-10-15 | Ripresa | Cowen | Market Perform |
| 2021-06-15 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2021-02-05 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-12-02 | Iniziato | Goldman | Sell |
| 2020-11-16 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2020-05-01 | Downgrade | Cleveland Research | Buy → Neutral |
| 2020-04-02 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| 2020-04-01 | Downgrade | Needham | Strong Buy → Hold |
| 2020-03-26 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-11-15 | Iniziato | Stifel | Hold |
| 2019-09-26 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | Aggiornamento | Goldman | Sell → Neutral |
| 2019-06-24 | Reiterato | Needham | Strong Buy |
| 2019-06-21 | Reiterato | BofA/Merrill | Neutral |
| 2019-05-30 | Iniziato | Wolfe Research | Peer Perform |
| 2019-05-06 | Reiterato | Needham | Strong Buy |
| 2019-05-03 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2019-05-03 | Aggiornamento | UBS | Sell → Neutral |
| 2019-04-12 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2019-02-12 | Reiterato | BTIG Research | Buy |
| 2019-01-03 | Iniziato | Needham | Strong Buy |
Mostra tutto
Bruker Corp Borsa (BRKR) Ultime notizie
Bruker Gains 66.3% in a Year: What's Driving the Rally? - Zacks Investment Research
Bruker announces proteome atlas: Bruker stock gains 1.14 percent - AD HOC NEWS
Bruker Corp (BRKR) Shares Fall 5.3% -- GF Value Says Still Overv - GuruFocus
Bruker Drops 6.5% Amid Sector-Wide Selling - AlphaStreet
Bruker (NASDAQ:BRKR) Stock Price Down 6.5%Time to Sell? - MarketBeat
Untargeted timsTOF Mass Spectrometry Enables Discovery and Mapping of Draft Atlas of the Human Plasma Proteome at Proteoform Resolution - Business Wire
Bruker stock adds a USD 6 million UC Berkeley order - AD HOC NEWS
Bruker Corporation (BRKR) Stock Price, News, Quote & History - Yahoo! Finance Canada
Are Options Traders Betting on a Big Move in Bruker Stock? - TradingView
Are Options Traders Betting on a Big Move in Bruker Stock? - Zacks Investment Research
Bruker Receives Order for High-Field NMR Systems for Major Upgrade of Magnetic Resonance Research Infrastructure at UC Berkeley - Moomoo
Bruker Stock Price Forecast. Should You Buy BRKR? - StockInvest.us
Why Bruker (BRKR) is a Top Momentum Stock for the Long-Term - Zacks Investment Research
Bruker Corp (BRKR) Shares Fall 4.3% -- GF Value Says Still Overv - GuruFocus
Bruker Slides as No Fresh Catalyst Emerges and Broader Risk-Off Mood Weighs - Quiver Quantitative
Bruker Corporation (BRKR) Stock Forecasts - Yahoo Finance
Bruker (NASDAQ:BRKR) Sets New 52-Week HighShould You Buy? - MarketBeat
Bruker Corporation stock hits 52-week high at 65.48 USD By Investing.com - Investing.com South Africa
Bruker Corporation stock hits 52-week high at 65.48 USD - Investing.com
Bruker (BRKR) Sets a New 52-Week High at $64.51 - 24/7 Wall St.
Long term debt to total assets ratio of Bruker Corporation – HAN:BKD - TradingView
Total liabilities & shareholders' equities of Bruker Corporation – HAN:BKD - TradingView
Bruker Corporation (BRKRP) Stock Price, News, Quote & History - Yahoo! Finance Canada
Bruker (BRKR) Unveils Advanced Protein-Sequence Analysis Workflo - GuruFocus
Bruker Corporation Announces New Timsultra Aip and Timsomni Workflows for Drug Discovery and Development and Disease Biology Research - marketscreener.com
Bruker unveils proteomics workflows at HUPO congress - Investing.com
MA-BRUKER-CORPORATION - The Facts
Bruker Advances Functional Proteomics with Novel timsUltra AIP and timsOmni Workflows for Drug Discovery & Development and Disease Biology Research - Rutland Herald
Bruker Advances Functional Proteomics with Novel timsUltra AIP and timsOmni Workflows for Drug Discovery & Development and Disease Biology Research - bdtonline.com
Bruker Advances Functional Proteomics with Novel timsUltra AIP and timsOmni Workflows for Drug Discovery & Development and Disease Biology Research - Business Wire
BRKR 10-Q FilingsBruker Corporation SEC 10-Q - Stock Titan
Bruker Sees AI-Fueled Semiconductor Demand, Targets Critical Q4 Revenue Rebound - Yahoo Finance
Bruker (BRKR) surges nearly 10% in a single session - 24/7 Wall St.
Bruker Corporation (BRKR) Stock Forecasts - Yahoo Finance
Automated Microscopy Market Advances as AI-Powered Image Analysis Transforms Digital Pathology and Semiconductor Inspection - GlobeNewswire Inc.
Global Metabolomics Market to Reach US$9.01 Billion by 2035 as Precision Medicine, Biomarker Discovery and Advanced Analytics Unlock New Opportunities - GlobeNewswire Inc.
Is Bruker (BRKR) Using Flagship Academic NMR Deals To Deepen Its High-End Moat? - Yahoo Finance
Bruker Gets More Than $6 Million Order From University of California, Berkeley - Yahoo Finance
55,937 Shares in Bruker Corporation $BRKR Purchased by Squarepoint Ops LLC - MarketBeat
Bruker Corporation at Wells Fargo Healthcare Conference Transcript - GuruFocus
Wellington Management Group LLP Invests $1.36 Million in Bruker Corporation $BRKR - MarketBeat
Can Bruker (BRKR) Stay Below Fair Value After Fusion News? - simplywall.st
Bruker advances whole-organism 3D imaging with enhanced tissue-clearing workflows - News-Medical
Bruker Corp (BRKR) Shares Fall 6.8% -- What GF Score of 86 Tells Investors - GuruFocus
Bruker Corporation at Wells Fargo Healthcare Conference Transcript - GuruFocus
UBS Adjusts Bruker Price Target to $65 From $45, Maintains Neutral Rating - Moomoo
Why Bruker (BRKR) Stock Is Falling Today - Yahoo Finance
Bruker (NASDAQ:BRKR) Shares Down 7.1%Time to Sell? - MarketBeat
UBS Group Begins Coverage on Bruker (NASDAQ:BRKR) - MarketBeat
Bruker at Wells Fargo Healthcare Conference: deep tech drives growth - investing.com
Bruker Corp Azioni (BRKR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Bruker Corp Azioni (BRKR) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| MARK R MUNCH | Officer |
Sep 15 '26 |
Proposed Sale |
52.87 |
2,000 |
105,740 |
0 |
| Munch Mark | EXEC VP&PRES BRUKER NANO INC. |
Sep 15 '26 |
Sale |
52.87 |
2,000 |
105,740 |
134,806 |
| Pusch Wolfgang | President BMID Group |
Aug 17 '26 |
Sale |
56.90 |
3,473 |
197,614 |
9,801 |
| WOLFGANG PUSCH | Officer |
Aug 17 '26 |
Proposed Sale |
56.90 |
3,473 |
197,614 |
0 |
| Munch Mark | EXEC VP&PRES BRUKER NANO INC. |
Aug 14 '26 |
Option Exercise |
22.19 |
2,000 |
44,380 |
125,347 |
| Munch Mark | EXEC VP&PRES BRUKER NANO INC. |
Aug 14 '26 |
Sale |
57.60 |
2,000 |
115,200 |
123,347 |
| MARK R MUNCH | Officer |
Aug 14 '26 |
Proposed Sale |
57.60 |
2,000 |
115,200 |
0 |
| MARK R MUNCH | Officer |
Jul 15 '26 |
Proposed Sale |
60.25 |
2,000 |
120,500 |
0 |
| Munch Mark | EXEC VP&PRES BRUKER NANO INC. |
Jul 15 '26 |
Option Exercise |
22.19 |
2,000 |
44,380 |
130,443 |
| Munch Mark | EXEC VP&PRES BRUKER NANO INC. |
Jul 15 '26 |
Sale |
60.25 |
2,000 |
120,500 |
128,443 |
7.73%
0.83%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):